Cargando…
Reporting bias in clinical trials: Progress toward transparency and next steps
Mayookha Mitra-Majumdar and Aaron Kesselheim reflect on steps taken to combat reporting bias in clinical trials over the last two decades.
Autores principales: | Mitra-Majumdar, Mayookha, Kesselheim, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769309/ https://www.ncbi.nlm.nih.gov/pubmed/35045078 http://dx.doi.org/10.1371/journal.pmed.1003894 |
Ejemplares similares
-
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022) -
Sexing Bones: Improving Transparency of Sex Reporting to Address Bias Within Preclinical Studies
por: Sharma, Aikta, et al.
Publicado: (2022) -
Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps
por: Bradley, Stephen H, et al.
Publicado: (2020) -
Clinical trial registration: An essential step toward transparency in clinical research
por: Garg, Rakesh, et al.
Publicado: (2023) -
Mitigating the Impact of COVID-19 on Funded Clinical Research: Crucial Next Steps
por: Walker, Rebekah J., et al.
Publicado: (2020)